iBio, Inc. Common Stock

IBIONASDAQ • USD
ThemeAI & Machine Learning›AI-Powered Analytics & Decision Systems
1.82 USD
↘ 0.11 (5.70%)AT CLOSE (11:59 AM EDT)
1.80
↘ 0.02 (1.04%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
1.80
↘ 0.02 (1.04%)
🔴Market: CLOSED
Open?$1.93
High?$2.09
Low?$1.73
Prev. Close?$1.93
Volume?2.3M
Avg. Volume?997.7K
VWAP?$1.94
Rel. Volume?2.29x
Bid / Ask
Bid?$1.81 × 100
Ask?$1.83 × 100
Spread?$0.02
Midpoint?$1.82
Valuation & Ratios
Market Cap?90.4M
Shares Out?49.7M
Float?31.5M
Float %?91.3%
P/E Ratio?N/A
P/B Ratio?1.17
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A

IBIO is currently priced at $1.82. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place IBIO at a fair price relative to peers.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Themes
AI & Machine Learning›AI-Powered Analytics & Decision SystemsBiotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
20
Market Cap
90.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ibioinc.com
Listed
2008-08-19
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
11
Momentum?
65
Short Sent.?
60
Piotroski F-Score?0/9Weak
Altman Z-Score?1.00Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.81%High
Short Interest?3.4M
Days to Cover?3.6
Free Float31.5M
Avg Daily Volume958.1K
Settlement Date2026-05-15
Financial Health
Current Ratio?11.88Strong
Quick Ratio?11.88Strong
Cash Ratio?7.32Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.17CHEAP▾
P/S?
Peers
100
S&P
3
301.38HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
142.61HIGH▾
Returns & Efficiency
ROE?
S&P
7
-24.1%WEAK▾
ROA?
S&P
3
-21.7%WEAK▾
Cash Flow & Enterprise
FCF?$-22181000
Enterprise Value?$42.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist